Capstone Investment Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-800
Closed -$164K 1828
2024
Q4
$164K Buy
800
+200
+33% +$43.9K ﹤0.01% 1632
2024
Q3
$146K Buy
600
+200
+50% +$46.8K ﹤0.01% 1648
2024
Q2
$87.8K Buy
400
+200
+100% +$43.4K ﹤0.01% 1905
2024
Q1
$45K Sell
200
-500
-71% -$113K ﹤0.01% 2213
2023
Q4
$154K Buy
+700
New +$148K ﹤0.01% 1852
2023
Q3
Sell
-600
Closed -$135K 2288
2023
Q2
$135K Hold
600
﹤0.01% 1644
2023
Q1
$115K Buy
+600
New +$116K ﹤0.01% 1353
2022
Q4
Sell
-2,700
Closed -$449K 1636
2022
Q3
$449K Sell
2,700
-200
-7% -$40.7K ﹤0.01% 1309
2022
Q2
$598K Sell
2,900
-6,400
-69% -$1.44M ﹤0.01% 1180
2022
Q1
$2.25M Buy
9,300
+4,400
+90% +$1.02M 0.01% 1003
2021
Q4
$1.19M Buy
4,900
+1,700
+53% +$388K ﹤0.01% 1251
2021
Q3
$654K Sell
3,200
-400
-11% -$85.6K ﹤0.01% 1513
2021
Q2
$743K Sell
3,600
-300
-8% -$60.4K ﹤0.01% 1309
2021
Q1
$743K Buy
3,900
+2,800
+255% +$519K ﹤0.01% 1192
2020
Q4
$208K Buy
1,100
+800
+267% +$149K ﹤0.01% 1450
2020
Q3
$53K Buy
+300
New +$48K ﹤0.01% 1359

Other funds holding STE

Capstone Investment Advisors's STE Position: Q1 2025 in Review

Capstone Investment Advisors sold out of Steris (STE) in Q1 2025, closing a stake of 2,657 shares — an estimated $546K sold.

Capstone Investment Advisors first reported a position in STE in Q4 2015 and held it in 13 quarters. The position peaked at $770K in Q1 2016. 779 funds tracked by Wall St. Rank hold STE as of Q1 2025.

  • Capstone Investment Advisors reported no remaining Steris position as of Q1 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,657 Steris shares in Q1 2025, an estimated $546K.
  • Capstone Investment Advisors first reported a position in Steris in Q4 2015 and held it in 13 quarters.
  • Capstone Investment Advisors's Steris position peaked at $770K in Q1 2016.
  • 779 funds tracked by Wall St. Rank held Steris as of Q1 2025.

Based on Capstone Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.